FGAM
CRBU icon

Financial Gravity Asset Management’s Caribou Biosciences CRBU Stock Holding History

Financial Gravity Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4
Closed -$4 – 1351
2023
Q2 		$4 Buy
+4
New +$18 ﹤0.01% 1591
2023
Q1 		– Sell
-6
Closed -$6 – 1243
2022
Q4 		$6 Buy
+6
New +$53 ﹤0.01% 1379

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Financial Gravity Asset Management's CRBU Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of Caribou Biosciences (CRBU) in Q3 2023, closing a stake of 4 shares — an estimated $4 sold.

Financial Gravity Asset Management first reported a position in CRBU in Q4 2022 and held it in 2 quarters. The position peaked at $6 in Q4 2022. 126 funds tracked by Wall St. Rank hold CRBU as of Q3 2023.

  • Financial Gravity Asset Management reported no remaining Caribou Biosciences position as of Q3 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 4 Caribou Biosciences shares in Q3 2023, an estimated $4.
  • Financial Gravity Asset Management first reported a position in Caribou Biosciences in Q4 2022 and held it in 2 quarters.
  • Financial Gravity Asset Management's Caribou Biosciences position peaked at $6 in Q4 2022.
  • 126 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.